Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Oceanobacillus iheyensis Protein ArsC (arsC) CSB-YP808063OAB
CSB-EP808063OAB
CSB-BP808063OAB
CSB-MP808063OAB
CSB-EP808063OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis tRNA (guanine-N (7)-)-methyltransferase (trmB) CSB-YP808064OAB
CSB-EP808064OAB
CSB-BP808064OAB
CSB-MP808064OAB
CSB-EP808064OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Probable tRNA sulfurtransferase (thiI) CSB-YP808065OAB
CSB-EP808065OAB
CSB-BP808065OAB
CSB-MP808065OAB
CSB-EP808065OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Acetyl-coenzyme A carboxylase carboxyl transferase subunit alpha (accA) CSB-YP808066OAB
CSB-EP808066OAB
CSB-BP808066OAB
CSB-MP808066OAB
CSB-EP808066OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Small, acid-soluble spore protein I (sspI) CSB-YP808067OAB
CSB-EP808067OAB
CSB-BP808067OAB
CSB-MP808067OAB
CSB-EP808067OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis MutS2 protein (mutS2), partial CSB-YP808068OAB
CSB-EP808068OAB
CSB-BP808068OAB
CSB-MP808068OAB
CSB-EP808068OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Valine--tRNA ligase (valS), partial CSB-YP808069OAB
CSB-EP808069OAB
CSB-BP808069OAB
CSB-MP808069OAB
CSB-EP808069OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP808070OAB
CSB-EP808070OAB
CSB-BP808070OAB
CSB-MP808070OAB
CSB-EP808070OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Histidine--tRNA ligase (hisS) CSB-YP808071OAB
CSB-EP808071OAB
CSB-BP808071OAB
CSB-MP808071OAB
CSB-EP808071OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Transcription elongation factor GreA (greA) CSB-YP808072OAB
CSB-EP808072OAB
CSB-BP808072OAB
CSB-MP808072OAB
CSB-EP808072OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Probable endonuclease 4 (nfo) CSB-YP808073OAB
CSB-EP808073OAB
CSB-BP808073OAB
CSB-MP808073OAB
CSB-EP808073OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Phosphopentomutase (deoB) CSB-YP808074OAB
CSB-EP808074OAB
CSB-BP808074OAB
CSB-MP808074OAB
CSB-EP808074OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Chorismate synthase (aroC) CSB-YP808075OAB
CSB-EP808075OAB
CSB-BP808075OAB
CSB-MP808075OAB
CSB-EP808075OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis UPF0302 protein OB1778 (OB1778) CSB-YP808076OAB
CSB-EP808076OAB
CSB-BP808076OAB
CSB-MP808076OAB
CSB-EP808076OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Putative membrane protein insertion efficiency factor (OB1687) CSB-YP808077OAB
CSB-EP808077OAB
CSB-BP808077OAB
CSB-MP808077OAB
CSB-EP808077OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Putative competence-damage inducible protein (cinA) CSB-YP808078OAB
CSB-EP808078OAB
CSB-BP808078OAB
CSB-MP808078OAB
CSB-EP808078OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Undecaprenyl pyrophosphate synthase (uppS) CSB-YP808079OAB
CSB-EP808079OAB
CSB-BP808079OAB
CSB-MP808079OAB
CSB-EP808079OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Ribosome maturation factor RimM (rimM) CSB-YP808080OAB
CSB-EP808080OAB
CSB-BP808080OAB
CSB-MP808080OAB
CSB-EP808080OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis UPF0435 protein OB1527 (OB1527) CSB-YP808081OAB
CSB-EP808081OAB
CSB-BP808081OAB
CSB-MP808081OAB
CSB-EP808081OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Oceanobacillus iheyensis Orotate phosphoribosyltransferase (pyrE) CSB-YP808082OAB
CSB-EP808082OAB
CSB-BP808082OAB
CSB-MP808082OAB
CSB-EP808082OAB-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>